The Indian pharmaceutical sector experienced a decline on March 4, 2026, amid broader market weakness. Early trading data showed the S&P BSE HEALTHCARE Index at 43,043.3, down 1.6%. The benchmark S&P BSE SENSEX stood at 78,597.26, down 2.05%, while the NIFTY 50 was at 24,332.35, down 2.14%.
Most pharmaceutical stocks listed on BSE and NSE traded lower as of 9:30 AM IST (BSE) and 9:34:59 AM IST (NSE). Notable declines included:
- Advanced Enzyme Technologies: BSE 285.20 (-3.45%), NSE 284.15 (-3.81%)
- Acutaas Chemicals: BSE 2,120.00 (-3.25%), NSE 2,121.40 (-3.22%)
- Concord Biotech: BSE 1,162.85 (-3.03%), NSE 1,161.20 (-3.31%)
- Jubilant Industries: BSE 1,639.05 (-4.08%), NSE 1,633.50 (-4.46%)
- Max Healthcare Institute: BSE 1,048.50 (-3.18%), NSE 1,050.60 (-3.05%)
Many large-cap pharma names also fell:
- Divi’s Laboratories: BSE 6,271.00 (-2.07%), NSE 6,285.00 (-1.85%)
- Sun Pharma: BSE 1,736.80 (-0.91%), NSE 1,743.90 (-0.49%)
- Cipla: BSE 1,334.40 (-1.29%), NSE 1,335.00 (-1.23%)
- Dr. Reddy’s Laboratories: BSE 1,280.70 (-1.08%), NSE 1,288.10 (-0.49%)
- Alkem Laboratories: BSE 5,486.55 (-1.60%), NSE 5,492.50 (-1.32%)
A few stocks bucked the trend with gains, such as Natco Pharma: BSE 978.60 (+2.32%), NSE 983.50 (+2.85%), and Emcure Pharmaceuticals: BSE 1,448.15 (+0.16%), NSE 1,460.70 (+1.07%).
Within the sector, top losers included some smaller names like Alpa Lab and Dr Habeebullah Life Sciences (down around 10%), while gainers featured Bharat Parenterals (up 6.8%) and Source Natural Foods (up 5.2%).
Broader market declines on March 4 followed sharp falls on March 2 due to geopolitical tensions in the Middle East, rising crude oil prices, and global risk aversion, contributing to selling across sectors including pharma. This update reflects early session data; stock prices can fluctuate throughout the trading day. Investors should monitor official exchange sources for real-time updates.